Vietnam minimally invasive biopsy techniques market size was valued at USD 46 million in 2022, which is expected to grow to USD 70.6 million in 2030, with a CAGR of 5.5% during the forecast period between 2023 and 2030F.
Home>Industry Reports>Vietnam Minimally Invasive Biopsy Techniques Market Assessment, Opportunities and Forecast, 2016-2030F
Vietnam minimally invasive biopsy techniques market size was valued at USD 46 million in 2022, expected to reach USD 70.6 million in 2030, with a CAGR of 5.5% for the forecast period between 2023 and 2030F. Vietnam's minimally invasive biopsy technique refers to using minimally invasive procedures to obtain tissue samples for diagnostic purposes. These techniques involve using specialized medical equipment and instruments to extract small tissue samples from the body, which medical professionals then analyze to diagnose diseases or conditions. In recent years, the demand for minimally invasive biopsy techniques has increased in Vietnam due to their benefits over traditional biopsy methods. These benefits include faster recovery times, reduced risk of complications, and less pain and discomfort to the patients.
The most common minimally invasive biopsy techniques used in Vietnam include ultrasound-guided biopsy, CT-guided biopsy, and endoscopic biopsy. These techniques allow doctors to obtain tissue samples from various organs and tissues, including the liver, lung, prostate, and breast. The market for minimally invasive biopsy techniques in Vietnam is expected to grow in the coming years due to technological advancements, increasing awareness among patients, and the rising prevalence of diseases such as cancer. However, challenges such as inflated costs and a shortage of trained medical professionals may hinder the market growth in Vietnam. For example, in 2023, Gene Solutions in Vietnam introduced an innovative liquid biopsy assay named SPOT-MAS, which employs a multimodal approach to identify the presence of the top five prevalent cancer types: liver, breast, colorectal, gastric, and lung cancers.
Rising Awareness Amongst the Patients
The rising awareness among patients about the benefits of minimally invasive procedures is a significant driver of the Vietnam minimally invasive biopsy techniques market. Patients are increasingly seeking procedures that offer less pain and discomfort, faster recovery times, and reduced risk of complications. Minimally invasive biopsy techniques such as ultrasound-guided, CT-guided, and endoscopic biopsy offer these benefits over traditional biopsy methods, often requiring larger incisions and longer recovery times. In addition, patients are becoming more educated about their healthcare options through the internet and social media, providing them with more information about minimally invasive procedures. In the forecast years, this increased awareness will continue driving the demand for minimally invasive biopsy techniques in Vietnam.
Advancements in Technology
Advancements in technology play a substantial role in driving the growth of the Vietnam minimally invasive biopsy techniques market. These advancements improve the accuracy and effectiveness of biopsy procedures while reducing the risk of patient complications and discomfort. One example is the development of improved imaging technologies, such as high-resolution ultrasound and CT scanners, allowing doctors to visualize the targeted tissue better and better guide the biopsy needle. In addition, advances in diagnostic tools, such as molecular testing and genomic analysis, have improved the accuracy of biopsy results, leading to more targeted and personalized treatment options for patients.
Furthermore, the use of robotic-assisted biopsy procedures is emerging as a promising technology in the minimally invasive biopsy techniques market, enabling doctors to perform highly accurate and minimally invasive procedures. These technological advancements are expected to continue driving the growth and innovation in the Vietnam minimally invasive biopsy techniques market. For instance, in 2022, a research paper highlighted that serum pepsinogen II levels and the pepsinogen I/II ratio demonstrated dependable diagnostic significance when identifying moderate and severe atrophic gastritis within the Vietnamese population. The study emphasized that these biomarkers could effectively screen individuals for these specific gastritis conditions.
Increasing Prevalence of Chronic Diseases
The escalating chronic diseases, including cancer, cardiovascular ailments, and respiratory disorders, have created a compelling need for more precise and less intrusive diagnostic methodologies. Among these techniques, minimally invasive biopsies have gained prominence due to their capacity to provide accurate diagnostic insights while minimizing patient discomfort and recovery times. As chronic diseases become more prevalent, healthcare providers and patients increasingly seek approaches that enable timely and accurate diagnoses, allowing for prompt intervention and treatment planning.
Consequently, the demand for minimally invasive biopsy procedures is on the rise, driven by the imperative to effectively address the diagnostic challenges posed by the growing burden of chronic diseases, ultimately leading to improved patient care and outcomes. For instance, an expert exclaimed, there are approximately 354,000 individuals in Vietnam grappling with cancer creating a stark contrast to the figures three decades ago. Moreover, this number is anticipated to surge in the years ahead. The notable surge in cancer prevalence is a key impetus behind the surge in interest for minimally invasive biopsy approaches. These advanced techniques offer reduced invasiveness and swifter recovery periods than conventional surgical biopsy methods.
Impact of COVID-19
The pandemic significantly impacted the Vietnam minimally invasive biopsy techniques market. The country has experienced multiple waves of the virus, resulting in various lockdowns and restrictions on medical procedures, including biopsy techniques. Many patients have hesitated to seek medical care due to the risk of infection. It has led to a decline in demand for minimally invasive biopsy procedures in Vietnam and a reduction in the number of procedures performed. Additionally, disruptions in the supply chain and global trade have led to shortages of medical equipment and supplies, causing delays in procedure scheduling and increasing costs. However, as the country's vaccination campaign continues and the situation improves, the demand for minimally invasive biopsy techniques is expected to rebound.
Vietnam Minimally Invasive Biopsy Techniques Market: Report Scope
“Vietnam Minimally Invasive Biopsy Techniques Market Assessment, Opportunities and Forecast, 2016-2030F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative & quantitative assessment of the current state of Minimally Invasive Biopsy Techniques market in Vietnam, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, COVID-19 and Russia-Ukraine war impact, opportunities, and forecast between 2023 and 2030F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
Details |
|
Base Year of the Analysis |
2022 |
Historical Period |
2016-2021 |
Forecast Period |
2023-2030F |
Projected Growth Rate |
CAGR of 5.5% between 2023 and 2030F |
Revenue Forecast in 2030 |
USD 70.6 billion |
Units |
Revenue in USD billion |
Segments Covered |
By Product Offered, By Technique, By Circulating Biomarker, By Application, By End-user, By Region |
Regions Covered |
Northern, Central, Southern |
Key Companies Profiled |
Medtronic plc, Becton, Dickinson, and Company, Boston Scientific Corporation, Roche Molecular Systems, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., Olympus Corporation |
Customization Scope |
15% free report customization with purchase |
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, Vietnam minimally invasive biopsy techniques market has been segmented into following categories:
1. By Product Offered
1.1. Tests
1.2. Kits & Consumables
1.3. Instruments
2. By Technique
2.1. Liquid Biopsy
2.2. Optical Biopsy
2.3. Brush Biopsy
2.4. Pigmented Lesion Assays
2.5. Others
3. By Circulating Biomarker
3.1. Circulating Tumor Cells (CTCs)
3.2. Cell Free DNA (cfDNA)
3.3. Circulating Tumor DNA (ctDNA)
3.4. Extracellular Vesicles
3.5. Others
4. By Application
4.1. Clinical
4.1.1.Treatment Monitoring
4.1.2.Prognosis & Recurrence Monitoring
4.1.3.Treatment Selection
4.1.4.Others
4.2. Therapeutic
4.2.1.Lung Cancer
4.2.2.Breast Cancer
4.2.3.Prostate Cancer
4.2.4.Colorectal Cancer
4.2.5.Others
5. By End-user
5.1. Hospitals & Clinics
5.2. Academic & Research Institutions
5.3. Ambulatory Care Centers
6. By Region
6.1. Northern
6.2. Central
6.3. Southern
Key Player Landscape and Outlook
The Vietnam minimally invasive biopsy techniques market is still nascent and dominated by a few key players. Companies are developing new and innovative products and technologies to improve the accuracy and efficiency of minimally invasive biopsy procedures. In addition, they are focusing on expanding their market reach through strategic partnerships, collaborations, and acquisitions. Despite the challenges posed by the COVID-19 pandemic, the outlook for the Vietnam minimally invasive biopsy techniques market remains positive, with growing demand for minimally invasive procedures and increasing investments in healthcare infrastructure, the growth is expected to drive in the coming years.
For instance, in 2023, evaluating the precision of the International Academy of Cytology Yokohama System in interpreting cytological results from breast fine needle aspiration biopsies was conducted at an oncology center in Vietnam. The study aimed to determine the system's effectiveness in diagnosing breast conditions accurately within the Vietnamese context.
Key Players Operating in Vietnam Minimally Invasive Biopsy Techniques Market are:
· Medtronic plc
· Becton, Dickinson, and Company
· Boston Scientific Corporation
· Roche Molecular Systems, Inc.
· Bio-Rad Laboratories, Inc.
· Beckman Coulter, Inc.
· QIAGEN N.V.
· Thermo Fisher Scientific Inc.
· Illumina, Inc.
· Agilent Technologies, Inc.
· Olympus Corporation
Markets and Data’s reports answer the following questions:
• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for Vietnam minimally invasive biopsy techniques market, you may approach our team at “info@marketsandata.com”
The pre-workout supplements market’s growth is augmented by the rising focus on physical health and well-being, increasing R&D investments for novel product development, and increasing awareness through partnerships with celebrities and appealing soc....Read More
Published on
December 2024
4,500
The market’s growth is boosted by the rising cases of pancreatic cancer across the globe, rising geriatric population more susceptible to pancreatic cancer, and advancements in treatment and diagnostic technologies.....Read More
Published on
December 2024
4,500
The rising requirement for surgical procedures supports the market’s growth due to the increasing number of road accidents and the rising prevalence of chronic conditions such as cancer and cardiovascular diseases. Moreover, the rising adoption of mi....Read More
Published on
December 2024
4,500
The respiratory care devices market is driven by the increasing prevalence of respiratory diseases, rising investments, technological advancements, an aging population, elevated pollution levels, and heightened awareness about respiratory health. The....Read More
Published on
November 2024
4,500
Purchase Options
USD ($)
i
1,840
2,000
8%
i
2,970
3,300
10%
i
3,960
4,500
12%
i
5,950
7,000
15%
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US